Hepatology

A major review suggests coffee’s bioactive compounds may help lower liver cancer risk, though benefits vary by intake, preparation method and individual lifestyle factors.

A new study suggests that the cholesterol-regulating protein PCSK9 may serve as a sensitive early biomarker for autoimmune liver diseases, helping identify patients even when routine liver tests appear normal.

New research shows that blood types A and B are linked to a higher risk of autoimmune liver disease.

Many people with primary biliary cholangitis are not receiving recommended alkaline phosphatase monitoring, and adherence is markedly higher among those under specialist care.

Semaglutide 2.4 mg/week reduced liver fibrosis and resolved MASH in the ESSENCE trial, offering dual hepatic and metabolic benefits.

New European research reveals that remission in autoimmune hepatitis does not guarantee recovery, with many patients reporting fatigue and poor quality of life.

Mazdutide, a dual GLP-1 and glucagon receptor agonist, significantly reduced liver fat and improved metabolic markers in people with MASLD and obesity.

New research found early Alzheimer’s markers in rats with liver dysfunction, suggesting liver health may play a key role in dementia risk.